Analyzing Novartis’ growth strategy: How the pharma giant is investing to improve drug development
We mined Novartis’ acquisitions, investments, and partnerships to discern the company's strategic priorities.
We mined Novartis’ acquisitions, investments, and partnerships to discern the company's strategic priorities.
Global digital health investment activity contracted in 2022, with funding falling by 57% year-over-year and deals reaching a 5-year low.
We outline the market outlook for patient-directed scheduling and navigation in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
Big tech is going after the $1T+ pharma market. Here’s how the tech titans are working to establish permanent places for themselves in the space through product launches, partnerships, M&A deals, and more.
From primary care to pharmacy benefits management, here's how companies are shaking up the healthcare space.
Proliferating super apps. Immortality-as-a-service. The rise of consumer robots. Smell goes digital. Here are the top tech trends poised to reshape industries in 2023.
We outline the market outlook for virtual assistants in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for VR therapeutics in the medical device industry — from investment trends, to leading companies, to recommendations for the players in the space.
We mined Medtronic's acquisitions, investments, and partnerships to understand the company's strategic priorities.
We outline the market outlook for real-world data in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for clinical documentation improvement in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for genomic profiling in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for digital biomarkers for vital signs in the pharma and clinical research industry – from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for patient data & analytics in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
As payers look for innovative ways to improve care at a lower cost, Cigna and Elevance Health (formerly Anthem) are exploring opportunities in digital therapeutics.
We outline the market outlook for smartphone-based diagnostics in the medical device industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for SDOH and community support in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for medical imaging artificial intelligence (AI) in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for member engagement in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for referral management in the healthcare industry — from investment trends, to leading companies, to recommendations for players in the space.
Thousands of technology buyers are using CB Insights to seek out vendors, partners, and M&A/investment targets. Our book highlights 140+ of the technology solutions that the world’s largest companies are looking for right now.
We outline the market outlook for population health analytics in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for diabetes DTx in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for patient payment solutions in the healthcare industry — from investment trends, to leading companies, to recommendations for players in the space.